It should be common in most European countries that have national health systems.
edit: Source: https://blogs.mediapart.fr/emmanuel-kosadinos/blog/310818/no...
edit: Source: https://blogs.mediapart.fr/emmanuel-kosadinos/blog/310818/no...
Then they maintain their incumbency and reduce a lot of their costs without a huge hit to revenue.
And if you’re a new pharma company with a truly awesome product, good luck getting anyone to prescribe it when you didn’t buy them a round of golf a decade ago because you didn’t exist.